Omixon

Thank you to everyone who attended Omixon’s User Group Meeting at #ASHI50. Connecting with so many passionate professionals in transplantation and immunogenetics was inspiring. A special congratulations to our amazing speakers— Jamie Duke, Runying Tian, and Karin Boer—who presented insightful sessions on key topics like full-coverage NanoTYPE HLA typing using Oxford Nanopore Technologies and the importance of frequent dd-cfDNA monitoring in kidney transplantation. These presentations generated tremendous interest, highlighting the importance of innovative scientific approaches in enhancing patient care. Our sessions' high attendance and engagement reflect the strength of our collaborations with leading laboratories and researchers worldwide. We are deeply grateful for your support in pushing the boundaries in transplant diagnostics and HLA typing. With such a strong foundation, we are excited about the future and the innovative solutions we can create together. #TransplantDiagnostics #HLA #ddcfDNA #Nanopore #OmixonIsNowWerfen #UGM #ASHI50

📢 15-16 Kasım tarihlerinde gerçekleşen Balkan EPT Toplantısı’nda KromoGEN olarak, distribütörlüğünü yaptığımız OMIXON’un transplantasyon immünolojisi ve HLA tiplendirme alanındaki yenilikçi ürünlerini tanıtıyoruz! OMIXON’un ileri teknolojisi, genetik analiz süreçlerinde çığır açıyor ve özellikle transplantasyon alanındaki laboratuvarların hassasiyetini ve verimliliğini artırıyor. Bu önemli etkinlikte sektörün değerli uzmanlarıyla bir araya gelerek OMIXON’un sunduğu çözümleri paylaşmaktan büyük memnuniyet duyuyoruz. 🔬 Yenilikçi ürünlerimizle sağlıkta daha iyi çözümler sunmaya devam ediyoruz! #KromoGEN #OMIXON #BalkanEPT #Transplantasyon #HLA #Genetik #Yenilik #Sağlık #NANOTYPE English: 📢 We are proudly representing KromoGEN at the Balkan EPT Meeting on November 15-16, showcasing OMIXON’s innovative products focused on transplantation immunology and HLA typing! OMIXON’s advanced technology is transforming genetic analysis, enhancing precision and efficiency in transplantation-related laboratory work. It is a pleasure to engage with industry leaders and highlight the transformative impact of OMIXON’s solutions at this pivotal event. 🔬 We continue to deliver better healthcare solutions through innovation! #KromoGEN #OMIXON #BalkanEPT #Transplantation #HLA #Genetics #Innovation #Healthcare #NANOTYPE

⬇️ TODAY | 12:40 | MARQUIS SOUTH ⬇️

ASHI 50th is in full swing! Visit us at booth #310! 🌊Dive into our latest product updates, and experience a hands-on NanoTYPE demo. 🏄🏻Make sure you don’t miss our SoCal-inspired merch! We’re excited to connect - see you! #OmixonIsNowWerfen

We are excited to become ONE with Werfen and contribute to powering patient care. You can continue to follow us here: -Corporate: Werfen -Austria: Werfen Germany and Austria -Benelux: Werfen Benelux -Brazil: Werfen Brazil -France: Werfen France -Germany: Werfen Germany and Austria -Italy: Werfen Italy -Mexico: Werfen Mexico -North America: Werfen North America -Portugal: Werfen Spain and Portugal -Spain: Werfen Spain and Portugal -UK: Werfen UK We will continue to offer our customers the service and dedication they are accustomed to, but now as Werfen, we will also expand the breadth of our impact, our commitment and offering to hospitals, clinical laboratories, and patients around the world. #PoweringPatientCare #SpecializedDiagnostics #NewNameNewLogo

Meet our Speakers at the Omixon User Group Meeting #ASHI50 Annual Meeting! Donor-derived cfDNA (dd-cfDNA) plays a crucial role in monitoring graft integrity and detection or exclusion of allograft rejection. We feel privileged that Karin Boer, PhD, Assistant Professor at the Erasmus MC Transplant Institute, University Medical Center Rotterdam will share her experiences with Omixon’s HoloGRAFT assay in the detection of dd-cfDNA in blood plasma after kidney transplantation. 📅 Date: Thursday, 24 October 🕒 Time: 12:40 PM - 1:35 PM 📍 Location: Marriott Anaheim, Marquis South Room Save the Date & Join Us! https://lnkd.in/dSr7BZ4T #Omixon #HoloGRAFT #HoloGRAFTONE #ddcfDNA #kidneytransplantation

Meet our Speakers at the Omixon User Group Meeting #ASHI50 Annual Meeting! It is with great honor that we introduce our industry expert speaker Runying Tian, MS, CHS (ACHI), Manager of the Transplantation Immunology Laboratory at Albany Medical College, who will present significant advancements and their implications in HLA typing using NanoTYPE. 📅 Date: Thursday, 24 October 🕒 Time: 12:40 PM - 1:35 PM 📍 Location: Marriott Anaheim, Marquis South Room Save the Date & Join Us! https://lnkd.in/dSr7BZ4T #ASHI2024 #Omixon #OmixonUGM #Transplantation #HLA #NanoTYPE #NanoTYPER

Meet our Speakers at the Omixon User Group Meeting at #ASHI50 Annual Meeting! We are excited to introduce our distinguished speaker Jamie Duke, PhD Principal Scientist at the Immunogenetics Laboratory at The Children's Hospital of Philadelphia who will be sharing key insights from the comprehensive validation study of Full-Coverage NanoTYPE. Don’t miss the chance to hear about the impact of this study and the future potential of NanoTYPE in transplant diagnostics. 📅 Date: Thursday, 24 October 🕒 Time: 12:40 PM - 1:35 PM 📍 Location: Marriott Anaheim, Marquis South Room Save the Date & Join Us! https://lnkd.in/dSr7BZ4T #ASHI2024 #Omixon #OmixonUGM #HLA #NanoTYPE #NanoTYPER

Special Announcement: NanoTYPER is Now IVDR Certified! We’re proud to announce that our NanoTYPER genotyping software has achieved IVDR certification, marking a significant milestone in the development of our NanoTYPE product line. A huge thank you to the Software and Bioinformatics Team for their dedication to developing this extraordinary software!  Special appreciation goes to our Senior Quality and Regulatory Engineer József Antal, PhD, whose commitment and strategic guidance played a key role in achieving this certification. Discover what’s new in NanoTYPER 2.1.0. This update is packed with powerful features that will take your experience to the next level, including: 🔢 Introduction of 4-field resolution for more precise analysis 🤖 Advanced automation for streamlined workflows 🧬 CDS numbering to boost clarity and insight 💡 Added support for serological types 🎛️ New noise tracking functionality to enhance accuracy 🧭 Significant improvements to the Gene Browser 📈 Further refinements for improved accuracy 🐞 Several important bug fixes We’re confident that these new tools and refinements will empower laboratories and researchers to achieve even more reliable results, with minimal effort. Try it now and experience the difference! https://lnkd.in/gENm_5Ec #NanoTYPER #IVDRCertified  #GenotypingSoftware #QualityAssurance #MedicalDeviceCompliance #OmixonMilestone #LifeSciencesInnovation

Join Us at the Omixon User Group Meeting #ASHI50 Annual! Attila Bérces, PhD, CEO and Founder of Omixon, and Maggi Woronkowicz, Commercial Director Americas, cordially invite you to our Omixon User Group Meeting. Join us for engaging conversations on the latest advancements in transplantation diagnostics. 📅 Date: Thursday, 24 October 🕒 Time: 12:40 PM - 1:35 PM 📍 Location: Marriott Anaheim, Marquis South Room Our expert guest speakers will explore a range of scientifically fascinating topics, including: - Full Coverage HLA NanoTYPE Typing using Oxford Nanopore Technologies - Donor-Derived cfDNA as a diagnostic tool in kidney transplantation This is an excellent opportunity to network with industry leaders and learn about new technologies shaping the future of transplantation. Don’t miss out! Save the Date & Join Us! https://lnkd.in/dSr7BZ4T #ASHI2024 #OmixonUGM #Transplantation #HLA #ddcfDNA #Diagnostics